Free

FreeIn Brief

GW launches the GW Cancer Center

GEORGE WASHINGTON UNIVERSITY has formally launched the GW Cancer Center. The GW Cancer Center is a collaboration between GW Hospital, The GW Medical Faculty Associates, the GW School of Medicine and Health Sciences, and the Milken Institute School of Public Health at GW, to expand GW’s efforts in the fight against cancer. The GW Cancer […]
FreeIn Brief

Parker Institute, CRI form collaboration on neoantigens

THE PARKER INSTITUTE for Cancer Immunotherapy and the Cancer Research Institute announced a Collaboration focused on neoantigens. The search for these unique cancer markers has become a robust area of research as scientists believe they may hold the key to developing a new generation of personalized, targeted cancer immunotherapies. The collaboration, the Tumor neoantigEn SeLection […]
FreeIn Brief

Hillman, Patti, Weinreb receive ACR Gold Medal

The American College of Radiology board of selected three innovators as 2017 Gold Medalists for their extraordinary service to the college or radiology. Honors will be presented bestowed during ACR 2017 – The Crossroads of Radiology meeting in Washington May 21-25, 2017. The following individuals will receive the ACR Gold Medal: Bruce Hillman, of Wake […]
FreeIn Brief

Coleman named VP of medical affairs at GenomOncology

JOSHUA COLEMAN was named vice president of medical affairs at GenomOncology. He will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting. […]
FreeIn Brief

Tempus, Abramson Cancer Center collaborate on immunotherapy

TEMPUS, a technology company focused on supporting physicians delivering customized cancer care, and the University of Pennsylvania Abramson Cancer Center partnered to better determine which patients will have a positive response to immunotherapy treatment based on next generation genomic and transcriptomic sequencing. As part of a research collaboration, Tempus will provide sequencing and analysis of […]
Drugs & TargetsFree

Amgen and Allergan seek EMA approval of biosimilar bevacizumab

AMGEN and Allergan plc submitted a Marketing Authorization Application to the European Medicines Agency for ABP 215, a biosimilar candidate to Avastin (bevacizumab). The companies said they this submission is the first bevacizumab biosimilar application submitted to the EMA. ABP 215 is a biosimilar candidate to bevacizumab, a recombinant immunoglobulin G1 monoclonal antibody that binds […]